CollPlant Biotechnologies (CLGN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on CollPlant Biotechnologies (CLGN) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.00 of bullish evidence against -0.52 bearish.

CollPlant Biotechnologies last closed at $3.51, -11.59% on the session.

Against the IVW growth benchmark the position is -12.39% over the forecast window.

The read is built from 15 underlying insights — 0 bullish and 15 bearish.

Agreement across those insights is 100%.

20 graded predictions for CLGN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

CollPlant Biotechnologies is classified under Health Care / Biotechnology, with a market capitalisation of $8.99M.

StockMap tracks CollPlant Biotechnologies as the 358th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite CollPlant Biotechnologies ranks 354th of 381 in the group, against a group median of -0.08.